Moller Financial Services continued to hold its stake in shares of CME Group Inc. (NASDAQ:CME) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,901 shares of the financial services provider’s stock at the end of the second quarter. Moller Financial Services’ holdings in CME Group were worth $238,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the company. Huntington National Bank increased its stake in shares of CME Group by 4.7% in the first quarter. Huntington National Bank now owns 851 shares of the financial services provider’s stock worth $100,000 after buying an additional 38 shares during the period. Coconut Grove Bank increased its stake in shares of CME Group by 95.7% in the first quarter. Coconut Grove Bank now owns 900 shares of the financial services provider’s stock worth $107,000 after buying an additional 440 shares during the period. Whittier Trust Co. increased its stake in shares of CME Group by 12.6% in the first quarter. Whittier Trust Co. now owns 1,030 shares of the financial services provider’s stock worth $122,000 after buying an additional 115 shares during the period. Parallel Advisors LLC increased its stake in shares of CME Group by 4.1% in the first quarter. Parallel Advisors LLC now owns 1,084 shares of the financial services provider’s stock worth $128,000 after buying an additional 43 shares during the period. Finally, RidgeWorth Capital Management LLC increased its stake in shares of CME Group by 55.5% in the first quarter. RidgeWorth Capital Management LLC now owns 1,138 shares of the financial services provider’s stock worth $135,000 after buying an additional 406 shares during the period. 83.29% of the stock is owned by institutional investors.

CME Group Inc. (NASDAQ:CME) opened at 123.26 on Friday. The company has a 50-day moving average price of $123.41 and a 200 day moving average price of $120.96. The firm has a market cap of $41.90 billion, a PE ratio of 25.16 and a beta of 0.73. CME Group Inc. has a 12 month low of $98.95 and a 12 month high of $127.96.

CME Group (NASDAQ:CME) last issued its earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.20 by $0.03. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The firm had revenue of $925 million for the quarter, compared to analysts’ expectations of $931.05 million. During the same quarter last year, the company posted $1.14 earnings per share. CME Group’s revenue was up 2.1% on a year-over-year basis. Equities research analysts anticipate that CME Group Inc. will post $4.81 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 25th. Shareholders of record on Friday, September 8th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $2.64 dividend on an annualized basis and a yield of 2.14%. CME Group’s dividend payout ratio is currently 53.99%.

ILLEGAL ACTIVITY WARNING: This news story was reported by Watch List News and is the property of of Watch List News. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright law. The legal version of this news story can be read at https://www.watchlistnews.com/cme-group-inc-cme-position-held-by-moller-financial-services/1478656.html.

A number of research firms have recently commented on CME. BidaskClub cut CME Group from a “hold” rating to a “sell” rating in a research report on Friday, July 28th. Royal Bank Of Canada lifted their target price on CME Group from $130.00 to $135.00 and gave the stock an “outperform” rating in a research report on Tuesday, June 20th. Jefferies Group LLC reiterated a “buy” rating and set a $134.00 target price (up previously from $128.00) on shares of CME Group in a research report on Monday, July 17th. Zacks Investment Research cut CME Group from a “hold” rating to a “sell” rating in a research report on Tuesday, July 11th. Finally, UBS AG reiterated a “buy” rating and set a $134.00 target price (down previously from $136.00) on shares of CME Group in a research report on Monday, June 5th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the company’s stock. CME Group presently has an average rating of “Hold” and an average price target of $131.63.

In other CME Group news, Director Martin J. Gepsman sold 200 shares of the firm’s stock in a transaction dated Wednesday, August 9th. The shares were sold at an average price of $126.14, for a total value of $25,228.00. Following the transaction, the director now owns 43,311 shares of the company’s stock, valued at $5,463,249.54. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Sunil Cutinho sold 10,265 shares of the firm’s stock in a transaction dated Wednesday, May 24th. The stock was sold at an average price of $117.85, for a total transaction of $1,209,730.25. Following the completion of the transaction, the insider now directly owns 21,690 shares in the company, valued at approximately $2,556,166.50. The disclosure for this sale can be found here. Insiders sold 91,085 shares of company stock worth $11,242,896 in the last three months. 0.61% of the stock is currently owned by corporate insiders.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.